Quick Answer
GE HealthCare Technologies Inc. reported Total Revenue of $20.62 billion for fiscal year 2025.
GE HealthCare Technologies Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $20.62B +4.8% |
$19.67B +0.6% |
$19.55B +6.6% |
$18.34B +4.3% |
$17.59B | — |
| Revenue (ASC 606) | $20.62B +4.8% |
$19.67B +0.6% |
$19.55B +6.6% |
$18.34B +4.3% |
$17.59B | — |
| Net Income | $2.08B +4.6% |
$1.99B +27.1% |
$1.57B -18.2% |
$1.92B -14.7% |
$2.25B | — |
| Diluted EPS | $4.55 +4.8% |
$4.34 +43.2% |
$3.03 -28.2% |
$4.22 -14.7% |
$4.95 | — |
| Total Assets | $36.91B +11.5% |
$33.09B +2.0% |
$32.45B +17.8% |
$27.54B | — | — |
| Long-Term Debt | $9.49B +27.5% |
$7.45B -11.7% |
$8.44B +2.5% |
$8.23B | — | — |
| Stockholders Equity | $10.38B +22.9% |
$8.45B +18.4% |
$7.13B -23.8% |
$9.36B -43.9% |
$16.68B +13.0% |
$14.75B |
| R&D Expense | $1.26B -3.9% |
$1.31B +8.8% |
$1.21B +17.4% |
$1.03B +25.7% |
$816.00M | — |
| Operating Income | $2.76B +5.3% |
$2.62B +7.8% |
$2.44B -3.4% |
$2.52B -9.8% |
$2.79B | — |
| Gross Profit | $8.25B +0.5% |
$8.21B +3.6% |
$7.92B +10.3% |
$7.18B +0.1% |
$7.17B | — |
| Shares Outstanding | — | — | 455.34M +455342190.0% |
100 | — | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $5.14B | +5.8% | +2.7% |
| Revenue (ASC 606) | September 30, 2025 | $5.14B | +5.8% | +2.7% |
| Net Income | September 30, 2025 | $446.00M | -5.1% | -8.2% |
| Diluted EPS | September 30, 2025 | $0.98 | -3.9% | -7.5% |
| Total Assets | September 30, 2025 | $36.13B | +6.7% | +1.8% |
| Long-Term Debt | September 30, 2025 | $8.28B | -11.1% | +0.1% |
| Stockholders Equity | September 30, 2025 | $9.99B | +20.2% | +2.9% |
| R&D Expense | September 30, 2025 | $292.00M | -7.6% | -3.3% |
| Operating Income | September 30, 2025 | $653.00M | -3.4% | -0.2% |
| Gross Profit | September 30, 2025 | $1.99B | -1.8% | +0.3% |
| Shares Outstanding | June 30, 2024 | 456.65M | +0.4% | +0.1% |
- GE HealthCare Technologies Inc. reported Total Revenue of $20.62 billion for fiscal year 2025.
- GE HealthCare Technologies Inc. showed an increase of +4.8% in Total Revenue compared to the prior fiscal year.
- GE HealthCare Technologies Inc. reported Revenue (ASC 606) of $20.62 billion for fiscal year 2025.
- GE HealthCare Technologies Inc. showed an increase of +4.8% in Revenue (ASC 606) compared to the prior fiscal year.
- GE HealthCare Technologies Inc. reported Net Income of $2.08 billion for fiscal year 2025.
- GE HealthCare Technologies Inc. showed an increase of +4.6% in Net Income compared to the prior fiscal year.
- GE HealthCare Technologies Inc. reported Diluted EPS of $4.55 per share for fiscal year 2025.
- GE HealthCare Technologies Inc. showed an increase of +4.8% in Diluted EPS compared to the prior fiscal year.
- GE HealthCare Technologies Inc. reported Total Assets of $36.91 billion for fiscal year 2025.
- GE HealthCare Technologies Inc. showed an increase of +11.5% in Total Assets compared to the prior fiscal year.
- GE HealthCare Technologies Inc. reported Long-Term Debt of $9.49 billion for fiscal year 2025.
- GE HealthCare Technologies Inc. showed an increase of +27.5% in Long-Term Debt compared to the prior fiscal year.
- GE HealthCare Technologies Inc. reported Stockholders Equity of $10.38 billion for fiscal year 2025.
- GE HealthCare Technologies Inc. showed an increase of +22.9% in Stockholders Equity compared to the prior fiscal year.
- GE HealthCare Technologies Inc. reported R&D Expense of $1.26 billion for fiscal year 2025.
- GE HealthCare Technologies Inc. showed a decrease of -3.9% in R&D Expense compared to the prior fiscal year.
- GE HealthCare Technologies Inc. reported Operating Income of $2.76 billion for fiscal year 2025.
- GE HealthCare Technologies Inc. showed an increase of +5.3% in Operating Income compared to the prior fiscal year.
- GE HealthCare Technologies Inc. reported Gross Profit of $8.25 billion for fiscal year 2025.
- GE HealthCare Technologies Inc. showed an increase of +0.5% in Gross Profit compared to the prior fiscal year.
- GE HealthCare Technologies Inc. reported Shares Outstanding of 455.34 million shares for fiscal year 2023.
- GE HealthCare Technologies Inc. showed an increase of +455342190.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: